CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Otsuka Holdings Company Limited Company Snapshot
Otsuka Holdings Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Otsuka Holdings Company Limited with three other companies in this sector in Japan: Daiichi Sankyo Company Limited (2018 sales of 960.20 billion Japanese Yen [US$8.57 billion] of which 92% was Prescription drugs), Astellas Pharma Incorporated (1.30 trillion Japanese Yen [US$11.61 billion] of which 45% was Other), and Takeda Pharmaceutical Company Limited (1.77 trillion Japanese Yen [US$15.81 billion] of which 96% was Pharmaceutical Business).

Sales Analysis. During the year ended December of 2018, sales at Otsuka Holdings Company Limited were ¥1.29 trillion (US$11.54 billion). This is an increase of 4.2% versus 2017, when the company's sales were ¥1.24 trillion. The sales level in 2018 was fairly close to the level five years ago: in 2013, Otsuka Holdings Company Limited had sales of ¥1.22 trillion. Sales of Nutraceuticals Related Business saw an increase of 7.6% in 2018, from ¥314.65 billion to ¥338.59 billion. Not all segments of Otsuka Holdings Company Limited experienced an increase in sales in 2018: sales of Other Businesses fell 10.9% to ¥102.63 billion. Otsuka Holdings Company Limited also experienced decreases in sales in Consumer-Related Business (down 4.8% to ¥33.65 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Otsuka Holdings Company Limited
  Stock Performance Chart for Otsuka Holdings Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 4,105.00
(Figures in Japanese Yen)
1 Week -6.5%   13 Weeks -12.7%  
4 Weeks -7.1%   52 Weeks -22.2%  
 
Otsuka Holdings Company Limited Key Data:
  Ticker: 4578 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,291,981,000,000
(Year Ending Jan 2019).
Employees: 32,935
  Currency: Japanese Yen Market Cap: 2,224,287,682,000
  Fiscal Yr Ends: December Shares Outstanding: 541,848,400
  Share Type: Common Closely Held Shares: 123,413,740
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.